These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1408825)

  • 61. Purification of MeCP2-containing deacetylase from Xenopus laevis.
    Jones PL; Wade PA; Wolffe AP
    Methods Mol Biol; 2002; 200():131-41. PubMed ID: 11951648
    [No Abstract]   [Full Text] [Related]  

  • 62. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
    Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
    Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Methyl CpG-binding proteins and transcriptional repression.
    Wade PA
    Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
    Jiang CL; Jin SG; Pfeifer GP
    J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chromosomal regulation by MeCP2: structural and enzymatic considerations.
    Bowen NJ; Palmer MB; Wade PA
    Cell Mol Life Sci; 2004 Sep; 61(17):2163-7. PubMed ID: 15338046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
    Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
    Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Solution structure of the matrix attachment region-binding domain of chicken MeCP2.
    Heitmann B; Maurer T; Weitzel JM; Strätling WH; Kalbitzer HR; Brunner E
    Eur J Biochem; 2003 Aug; 270(15):3263-70. PubMed ID: 12869202
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
    Balmer D; Arredondo J; Samaco RC; LaSalle JM
    Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain.
    Mullaney BC; Johnston MV; Blue ME
    Neuroscience; 2004; 123(4):939-49. PubMed ID: 14751287
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The neurobiology of Rett syndrome.
    Akbarian S
    Neuroscientist; 2003 Feb; 9(1):57-63. PubMed ID: 12580340
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MeCP2 and other methyl-CpG binding proteins.
    Jørgensen HF; Bird A
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.
    Fujita N; Shimotake N; Ohki I; Chiba T; Saya H; Shirakawa M; Nakao M
    Mol Cell Biol; 2000 Jul; 20(14):5107-18. PubMed ID: 10866667
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.
    Ohki I; Shimotake N; Fujita N; Jee J; Ikegami T; Nakao M; Shirakawa M
    Cell; 2001 May; 105(4):487-97. PubMed ID: 11371345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor.
    Prokhortchouk A; Hendrich B; Jørgensen H; Ruzov A; Wilm M; Georgiev G; Bird A; Prokhortchouk E
    Genes Dev; 2001 Jul; 15(13):1613-8. PubMed ID: 11445535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
    Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
    Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dynamic regulation of DNA methylation coupled transcriptional repression: BDNF regulation by MeCP2.
    Wade PA
    Bioessays; 2004 Mar; 26(3):217-20. PubMed ID: 14988922
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties.
    Fraga MF; Ballestar E; Montoya G; Taysavang P; Wade PA; Esteller M
    Nucleic Acids Res; 2003 Mar; 31(6):1765-74. PubMed ID: 12626718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions.
    Piccolo FM; Liu Z; Dong P; Hsu CL; Stoyanova EI; Rao A; Tjian R; Heintz N
    Elife; 2019 Dec; 8():. PubMed ID: 31868585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.